Condition
Nasolabial Fold, Hypoplastic
Total Trials
3
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06533540Phase 1Active Not RecruitingPrimary
Safety Study of TPX-121 on Nasolabial Folds
NCT03050710Not ApplicableCompletedPrimary
Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds
NCT04101825Not ApplicableCompletedPrimary
MD Auralia (HA Filler) in Treatment of Nasolabial Wrinkles
Showing all 3 trials